CybeRelease: (OTC: PMRS) Changing Name to Auto íVí Resources
(CybeRelease, March 29, 2007) Ė Lake Harmony, Pa. - Premier Mortgage Resources Inc. (OTC PK: PMRS) announced that it is changing its name to Auto íVí Resources, Inc. The name change has been approved and a new CUSIP number has been assigned. Management has filed for a new trading symbol, which will be announced upon approval.
As part of the companyís restructuring, the Board of Directors has been expanded to include Steven Brown and Edward Herbert. In addition to their new duties on the Board, Mr. Brown will serve as President and Treasurer, and Mr. Herbert as Chief Operating Officer and Secretary.
ďNow that PMRS is in the final stages of its acquisition of Auto íVí Grooving, it is the ideal time to integrate the management teams of the two companies,Ē says Steven Brown. ďWe feel that the name Auto íVí Resources more accurately reflects the primary operation of the new company. As President, I look forward to devoting my efforts to increasing Auto íVís profile.Ē
About Auto íVí Grooving Inc.
Based in Toronto, Ontario, Auto íVí Grooving Inc. is the innovator of the v-grooving fabrication process, and manufactures a line of high precision machinery incorporating this revolutionary technique. Over the last 35 years, more than 1,600 machines have been installed worldwide, all of them still in full production operation. The company currently markets its equipment through major industry trade shows, direct sales and on the Internet.
To read the complete release, go to http://biz.yahoo.com/iw/070328/0232245.html
For a Free Newsletter, go to http://www.OTCReporter.com
CybeRelease Gainers are Activision, Inc. (Nasdaq: ATVI), Blackbaud, Inc. (Nasdaq: BLKB), Lumera Corporation (Nasdaq: LMRA), Syntax-Brillian Corporation (Nasdaq: BRLC), Vyyo, Inc. (Nasdaq: VYYO), Blue Dolphin Energy Company (Nasdaq: BDCO), Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and CEPHEID (Nasdaq: CPHD).
CybeRelease Decliners are CMGI, Inc. (Nasdaq: CMGI), AtheroGenics, Inc. (Nasdaq: AGIX), CV Therapeutics, Inc. (Nasdaq: CVTX), AngioDynamics, Inc. (Nasdaq: ANGO), Sigma Designs, Inc. (Nasdaq: SIGM), OmniVision Technologies, Inc. (Nasdaq: OVTI), ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) and Onstream Media Corporation (Nasdaq: ONSM).
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investorís reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.
- Contact Information
- C. P. Barry
- Media Contact
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.